p53 modulates cancer metabolism via the liver kinase B1 (LKB1) and AMPK pathways [41], and reduced expression of LKB1 in EAC enhances tumor metastasis and the tumor stage and decreases OS in patients with EAC [42]. The gene discussed is TP53; the disease is neoplasm.